Malalis, Jose R.
HRN: 22-78-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/18/2024
01/24/2024
IV INFUSION
1.5gm
Q8
Pneumonia; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes